ExodusPoint Capital Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

ExodusPoint Capital Management’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-18,184	Closed	-$51K	–	2331
2023 Q1	$51K	Buy	+18,184	New	+$52K	﹤0.01%	1664
2022 Q3	–	Sell	-11,016	Closed	-$27K	–	2395
2022 Q2	$27K	Sell	11,016 -204,312	-95%	-$537K	﹤0.01%	1840
2022 Q1	$887K	Buy	+215,328	New	+$1.14M	0.01%	1231
2021 Q3	–	Sell	-13,093	Closed	-$120K	–	2768
2021 Q2	$120K	Sell	13,093 -2,800	-18%	-$25.9K	﹤0.01%	2112
2021 Q1	$150K	Sell	15,893 -13,718	-46%	-$189K	﹤0.01%	1922
2020 Q4	$117K	Buy	+29,611	New	+$89.6K	﹤0.01%	1815

Other funds holding GRTS

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ExodusPoint Capital Management's GRTS Position: Q2 2023 in Review

ExodusPoint Capital Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2023, closing a stake of 18,184 shares — an estimated $51K sold.

ExodusPoint Capital Management first reported a position in GRTS in Q4 2020 and held it in 6 quarters. The position peaked at $887K in Q1 2022. 88 funds tracked by Wall St. Rank hold GRTS as of Q2 2023.

ExodusPoint Capital Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
ExodusPoint Capital Management sold 18,184 Gritstone bio, Inc. Common Stock shares in Q2 2023, an estimated $51K.
ExodusPoint Capital Management first reported a position in Gritstone bio, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
ExodusPoint Capital Management's Gritstone bio, Inc. Common Stock position peaked at $887K in Q1 2022.
88 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2023.

Based on ExodusPoint Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.